CVKD: Cadrenal Therapeutics Inc Financial Statements
Balance sheet, income statement, and cash flow statements for Cadrenal Therapeutics Inc (CVKD).
$24.04M Market Cap.
CVKD Market Cap. (MRY)
CVKD Shares Outstanding (MRY)
CVKD Assets (MRY)
Total Assets
$10.12M
Total Liabilities
$2.68M
Total Investments
$0
CVKD Income (MRY)
Revenue
$0
Net Income
-$10.65M
Operating Expense
$10.96M
CVKD Cash Flow (MRY)
CF Operations
-$7.36M
CF Investing
-$6.54K
CF Financing
$8.98M
CVKD Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 |
|---|---|---|---|
Total Assets | $10,123,533 (18.83%) | $8,519,250 (994.77%) | $778,174 |
Assets Current | $10,112,797 (19.08%) | $8,492,173 (1067.15%) | $727,596 |
Assets Non-Current | $10,736 (-60.35%) | $27,077 (-46.46%) | $50,578 |
Goodwill & Intangible Assets | $0 (0%) | $0 (0%) | $0 |
Shareholders Equity | $7,439,575 (-3.29%) | $7,692,375 (238.57%) | -$5,551,150 |
Property Plant & Equipment Net | $6,944 (-70.18%) | $23,285 (-47.78%) | $44,591 |
Cash & Equivalents | $10,017,942 (19.23%) | $8,402,500 (25685.61%) | $32,586 |
Accumulated Other Comprehensive Income | $0 (0%) | $0 (0%) | $0 |
Deferred Revenue | $0 (0%) | $0 (0%) | $0 |
Total Investments | $0 (0%) | $0 (0%) | $0 |
Investments Current | $0 (0%) | $0 (0%) | $0 |
Investments Non-Current | $0 (0%) | $0 (0%) | $0 |
Inventory | $0 (0%) | $0 (0%) | $0 |
Trade & Non-Trade Receivables | $0 (0%) | $0 (0%) | $0 |
Trade & Non-Trade Payables | $1,502,468 (797.97%) | $167,319 (-58.68%) | $404,897 |
Accumulated Retained Earnings (Deficit) | -$25,722,783 (-70.67%) | -$15,071,415 (-124.47%) | -$6,714,329 |
Tax Assets | $0 (0%) | $0 (0%) | $0 |
Tax Liabilities | $0 (0%) | $0 (0%) | $0 |
Total Debt | $0 (0%) | $21,350 (-96.67%) | $640,706 |
Debt Current | $0 (0%) | $21,350 (-67.66%) | $66,016 |
Debt Non-Current | $0 (0%) | $0 (0%) | $574,690 |
Total Liabilities | $2,683,958 (224.59%) | $826,875 (-86.94%) | $6,329,324 |
Liabilities Current | $2,683,958 (224.59%) | $826,875 (-38.04%) | $1,334,477 |
Liabilities Non-Current | $0 (0%) | $0 (0%) | $4,994,847 |
CVKD Income Statement (MRY)
Metric | 2024 | 2023 | 2022 |
|---|---|---|---|
Revenues | $0 (0%) | $0 (0%) | $0 |
Cost of Revenue | $0 (0%) | $0 (0%) | $0 |
Selling General & Administrative Expense | $6,753,726 (90.27%) | $3,549,514 (53.82%) | $2,307,503 |
Research & Development Expense | $4,205,013 (3.03%) | $4,081,349 (938.88%) | $392,859 |
Operating Expenses | $10,960,619 (43.60%) | $7,632,843 (182.53%) | $2,701,628 |
Interest Expense | $0 (0%) | $17,101 (-84.03%) | $107,105 |
Income Tax Expense | $0 (0%) | $0 (0%) | $0 |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 |
Consolidated Income | -$10,651,368 (-27.45%) | -$8,357,086 (-24.47%) | -$6,714,329 |
Net Income to Non-Controlling Interests | $0 (0%) | $0 (0%) | $0 |
Net Income | -$10,651,368 (-27.45%) | -$8,357,086 (-24.47%) | -$6,714,329 |
Preferred Dividends Income Statement Impact | $0 (0%) | $0 (0%) | $0 |
Net Income Common Stock | -$10,651,368 (-27.45%) | -$8,357,086 (-24.47%) | -$6,714,329 |
Weighted Average Shares | $1,219,550 (-90.96%) | $13,491,980 (70.99%) | $7,890,507 |
Weighted Average Shares Diluted | $1,219,550 (-90.96%) | $13,491,980 (70.99%) | $7,890,507 |
Earning Before Interest & Taxes (EBIT) | -$10,651,368 (-27.71%) | -$8,339,985 (-26.23%) | -$6,607,224 |
Gross Profit | $0 (0%) | $0 (0%) | $0 |
Operating Income | -$10,960,619 (-43.60%) | -$7,632,843 (-182.53%) | -$2,701,628 |
CVKD Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 |
|---|---|---|---|
Net Cash Flow from Investing | -$6,537 (-100.89%) | -$3,254 (-42.78%) | -$2,279 |
Net Cash Flow from Financing | $8,979,529 (-24.56%) | $11,903,491 (860.24%) | $1,239,635 |
Net Cash Flow from Operations | -$7,357,550 (-108.41%) | -$3,530,323 (-193.03%) | -$1,204,770 |
Net Cash Flow / Change in Cash & Cash Equivalents | $1,615,442 (-80.70%) | $8,369,914 (25585.61%) | $32,586 |
Net Cash Flow - Business Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 |
Net Cash Flow - Investment Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 |
Capital Expenditure | -$6,537 (-100.89%) | -$3,254 (-42.78%) | -$2,279 |
Issuance (Repayment) of Debt Securities | $0 (0%) | -$250,000 (-120.30%) | $1,231,685 |
Issuance (Purchase) of Equity Shares | $9,317,168 (-23.34%) | $12,153,491 (152774.10%) | $7,950 |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 |
Effect of Exchange Rate Changes on Cash | $0 (0%) | $0 (0%) | $0 |
Share Based Compensation | $1,419,039 (99.76%) | $710,381 (-23.45%) | $928,049 |
Depreciation Amortization & Accretion | $1,528 (-32.75%) | $2,272 (79.46%) | $1,266 |
CVKD Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 |
|---|---|---|---|
Gross Margin | - | - | - |
Profit Margin | - | - | - |
EBITDA Margin | - | - | - |
Return on Average Equity (ROAE) | -202.50% (-43.41%) | -141.20% | - |
Return on Average Assets (ROAA) | -156.00% (-20.74%) | -129.20% | - |
Return on Sales (ROS) | - | - | - |
Return on Invested Capital (ROIC) | 865.40% (-75.49%) | 3531.00% | - |
Dividend Yield | 0% (0%) | 0% | - |
Price to Earnings Ratio (P/E) | -1.66 (-39.15%) | -1.19 | - |
Price to Sales Ratio (P/S) | - | - | - |
Price to Book Ratio (P/B) | 3.23 (157.86%) | 1.25 | - |
Debt to Equity Ratio (D/E) | 0.36 (237.38%) | 0.11 (109.39%) | -1.14 |
Earnings Per Share (EPS) | -8.73 (-1308.06%) | -0.62 (27.06%) | -0.85 |
Sales Per Share (SPS) | 0 (0%) | 0 (0%) | 0 |
Free Cash Flow Per Share (FCFPS) | -6.04 (-2204.58%) | -0.26 (-71.24%) | -0.15 |
Book Value Per Share (BVPS) | 6.1 (970.18%) | 0.57 (180.97%) | -0.7 |
Tangible Assets Book Value Per Share (TABVPS) | 8.3 (1215.53%) | 0.63 (537.37%) | 0.1 |
Enterprise Value Over EBIT (EV/EBIT) | -2 (0%) | 0 | - |
Enterprise Value Over EBITDA (EV/EBITDA) | -1.85 (-2698.48%) | -0.07 | - |
Asset Turnover | 0 (0%) | 0 | - |
Current Ratio | 3.77 (-63.31%) | 10.27 (1784.40%) | 0.55 |
Dividends | $0 (0%) | $0 (0%) | $0 |
Free Cash Flow (FCF) | -$7,364,087 (-108.40%) | -$3,533,577 (-192.75%) | -$1,207,049 |
Enterprise Value (EV) | $19,673,924 (3455.74%) | $553,301 | - |
Earnings Before Tax (EBT) | -$10,651,368 (-27.45%) | -$8,357,086 (-24.47%) | -$6,714,329 |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | -$10,649,840 (-27.73%) | -$8,337,713 (-26.22%) | -$6,605,958 |
Invested Capital | -$2,578,367 (-274.34%) | -$688,775 (-1429.25%) | $51,817 |
Working Capital | $7,428,839 (-3.08%) | $7,665,298 (1363.06%) | -$606,881 |
Tangible Asset Value | $10,123,533 (18.83%) | $8,519,250 (994.77%) | $778,174 |
Market Capitalization | $24,035,592 (149.45%) | $9,635,523 | - |
Average Equity | $5,259,074 (-11.16%) | $5,919,845 | - |
Average Assets | $6,827,107 (5.55%) | $6,467,990 | - |
Invested Capital Average | -$1,230,736 (-421.07%) | -$236,196 | - |
Shares | 1,658,771 (-87.26%) | 13,022,754 (58.93%) | 8,193,875 |
